These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. VX-950, a novel hepatitis C virus (HCV) NS3-4A protease inhibitor, exhibits potent antiviral activities in HCv replicon cells. Lin K; Perni RB; Kwong AD; Lin C Antimicrob Agents Chemother; 2006 May; 50(5):1813-22. PubMed ID: 16641454 [TBL] [Abstract][Full Text] [Related]
10. Preclinical characterization of the novel HCV NS3 protease inhibitor GS-9256. Yang H; Yang C; Wang Y; Rhodes G; Robinson M; Cheng G; Qi X; Mo H; Tian Y; Pakdaman R; Sheng XC; Kim CU; Delaney WE Antivir Ther; 2017; 22(5):413-420. PubMed ID: 28106531 [TBL] [Abstract][Full Text] [Related]
11. In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons. Yu M; Corsa AC; Xu S; Peng B; Gong R; Lee YJ; Chan K; Mo H; Delaney W; Cheng G Antiviral Res; 2013 Nov; 100(2):439-45. PubMed ID: 24013001 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of Pycnogenol® on hepatitis C virus replication. Ezzikouri S; Nishimura T; Kohara M; Benjelloun S; Kino Y; Inoue K; Matsumori A; Tsukiyama-Kohara K Antiviral Res; 2015 Jan; 113():93-102. PubMed ID: 25446333 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of hepatitis C virus replication by GS-6620, a potent C-nucleoside monophosphate prodrug. Feng JY; Cheng G; Perry J; Barauskas O; Xu Y; Fenaux M; Eng S; Tirunagari N; Peng B; Yu M; Tian Y; Lee YJ; Stepan G; Lagpacan LL; Jin D; Hung M; Ku KS; Han B; Kitrinos K; Perron M; Birkus G; Wong KA; Zhong W; Kim CU; Carey A; Cho A; Ray AS Antimicrob Agents Chemother; 2014; 58(4):1930-42. PubMed ID: 24419349 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy. Okuse C; Rinaudo JA; Farrar K; Wells F; Korba BE Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968 [TBL] [Abstract][Full Text] [Related]
16. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons. Jarczak D; Korf M; Beger C; Manns MP; Krüger M FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954 [TBL] [Abstract][Full Text] [Related]
17. A serine palmitoyltransferase inhibitor blocks hepatitis C virus replication in human hepatocytes. Katsume A; Tokunaga Y; Hirata Y; Munakata T; Saito M; Hayashi H; Okamoto K; Ohmori Y; Kusanagi I; Fujiwara S; Tsukuda T; Aoki Y; Klumpp K; Tsukiyama-Kohara K; El-Gohary A; Sudoh M; Kohara M Gastroenterology; 2013 Oct; 145(4):865-73. PubMed ID: 23791700 [TBL] [Abstract][Full Text] [Related]